Stefano Salvioli

Dr. Stefano Salvioli


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2017 in Frontiers in Immunology
Verified
Journal Article
Open access
CFClaudio Franceschi
Claudio Franceschi
SSStefano Salvioli
Stefano Salvioli
PGPaolo Garagnani
Paolo Garagnani
MEMagda de Eguileor
Magda de Eguileor
DMDaniela Monti
Daniela Monti
MCMiriam Capri
Miriam Capri
Owing to its memory and plasticity, the immune system (IS) is capable of recording all the immunological experiences and stimuli it was exposed to. The combination of type, dose, intensity and temporal sequence of antigenic stimuli that each individual is exposed to has been named “immunobiography”. This immunological history induces a lifelong continuous adaptation of the IS, which is responsible for the capability to mount strong, weak or no response to specific antigens, thus determining the large heterogeneity of immunological responses. In the last years it is becoming clear that memory is not solely a feature of adaptive immunity, as it has been observed that also innate immune cells are provided with a sort of memory, dubbed “trained immunity”. In this review, we discuss the main characteristics of trained immunity as a possible contributor to inflammaging within the perspective of immunobiography, with particular attention to the phenotypic changes of the cell populations known to be involved in trained immunity. In conclusion, immunobiography emerges as a pervasive and comprehensive concept that could help in understanding and interpret the individual heterogeneity of immune responses (to infections and vaccinations) that becomes particularly evident at old age and could affect immunosenescence and inflammaging.

9 April 2015 in Nutrients
Verified
Journal Article
Open access
PDF file
RORita Ostan
Rita Ostan
CLCatia Lanzarini
Catia Lanzarini
EPElisa Pini
Elisa Pini
SMScurti Maria
Scurti Maria
DVDario Vianello
Dario Vianello
ASAurelia Santoro
Aurelia Santoro
Aging is considered the major risk factor for cancer, one of the most important mortality causes in the western world. Inflammaging, a state of chronic, low-level systemic inflammation, is a pervasive feature of human aging. Chronic inflammation increases cancer risk and affects all cancer stages, triggering the initial genetic mutation or epigenetic mechanism, promoting cancer initiation, progression and metastatic diffusion. Thus, inflammaging is a strong candidate to connect age and cancer. A corollary of this hypothesis is that interventions aiming to decrease inflammaging should protect against cancer, as well as most/all age-related diseases. Epidemiological data are concordant in suggesting that the Mediterranean Diet (MD) decreases the risk of a variety of cancers but the underpinning mechanism(s) is (are) still unclear. Here we review data indicating that the MD (as a whole diet or single bioactive nutrients typical of the MD) modulates multiple interconnected processes involved in carcinogenesis and inflammatory response such as free radical production, NF-κB activation and expression of inflammatory mediators, and the eicosanoids pathway. Particular attention is devoted to the capability of MD to affect the balance between pro- and anti-inflammaging as well as to emerging topics such as maintenance of gut microbiota (GM) homeostasis and epigenetic modulation of oncogenesis through specific microRNAs.

28 August 2023 in Ageing Research Reviews
Verified
Journal Article
Open access
SSStefano Salvioli
Stefano Salvioli
MBMaria Sofia Basile
Maria Sofia Basile
LBLeonardo Bencivenga
Leonardo Bencivenga
SCSara Carrino
Sara Carrino
MCMaria Conte
Maria Conte
FLFabrizia Lattanzio
Fabrizia Lattanzio
According to the Geroscience concept that organismal aging and age-associated diseases share the same basic molecular mechanisms, the identification of biomarkers of age that can efficiently classify people as biologically older (or younger) than their chronological (i.e. calendar) age is becoming of paramount importance. These people will be in fact at higher (or lower) risk for many different age-associated diseases, including cardiovascular diseases, neurodegeneration, cancer, etc. In turn, patients suffering from these diseases are biologically older than healthy age-matched individuals. Many biomarkers that correlate with age have been described so far. The aim of the present review is to discuss the usefulness of some of these biomarkers (especially soluble, circulating ones) in order to identify frail patients, possibly before the appearance of clinical symptoms, as well as patients at risk for age-associated diseases. An overview of selected biomarkers will be discussed in this regard, in particular we will focus on biomarkers related to metabolic stress response, inflammation, and cell death (in particular in neurodegeneration), all phenomena connected to inflammaging (chronic, low-grade, age-associated inflammation). In the second part of the review, next-generation markers such as extracellular vesicles and their cargos, epigenetic markers and gut microbiota composition, will be discussed. Since recent progresses in omics techniques have allowed an exponential increase in the production of laboratory data also in the field of biomarkers of age, making it difficult to extract biological meaning from the huge mass of available data, Artificial Intelligence (AI) approaches will be discussed as an increasingly important strategy for extracting knowledge from raw data and providing practitioners with actionable information to treat patients.

1 April 2014 in Aging
Verified
Journal Article
Open access
GSGianluca Sgarbi
Gianluca Sgarbi
PMPaola Matarrese
Paola Matarrese
Marcello PintiMarcello Pinti
Marcello Pinti
CLCatia Lanzarini
Catia Lanzarini
BABarbara Ascione
Barbara Ascione
SSStefano Salvioli
Stefano Salvioli
Mitochondria have been considered for long time as important determinants of cell aging because of their role in the production of reactive oxygen species. In this study we investigated the impact of mitochondrial metabolism and biology as determinants of successful aging in primary cultures of fibroblasts isolated from the skin of long living individuals (LLI) (about 100 years old) compared with those from young (about 27 years old) and old (about 75 years old) subjects. We observed that fibroblasts from LLI displayed significantly lower complex I-driven ATP synthesis and higher production of H2O2 in comparison with old subjects. Despite these changes, bioenergetics of these cells appeared to operate normally. This lack of functional consequences was likely due to a compensatory phenomenon at the level of mitochondria, which displayed a maintained supercomplexes organization and an increased mass. This appears to be due to a decreased mitophagy, induced by hyperfused, elongated mitochondria. The overall data indicate that longevity is characterized by a preserved bioenergetic function likely attained by a successful mitochondria remodeling that can compensate for functional defects through an increase in mass, i.e. a sort of mitochondrial "hypertrophy".

12 May 2013 in Biogerontology
Verified
Journal Article
Closed access
PDF file
LBLaura Bucci
Laura Bucci
SYStella Lukas Yani
Stella Lukas Yani
CFCristina Fabbri
Cristina Fabbri
ABAstrid Y. Bijlsma
Astrid Y. Bijlsma
Andrea Britta MaierAndrea Britta Maier
Andrea Britta Maier
SSStefano Salvioli
Stefano Salvioli

24 November 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AGAlessandro Ghezzo
Alessandro Ghezzo
SSStefano Salvioli
Stefano Salvioli
MSMaria Caterina Solimando
Maria Caterina Solimando
APAlice Palmieri
Alice Palmieri
CCChiara Chiostergi
Chiara Chiostergi
CFClaudio Franceschi
Claudio Franceschi
Down Syndrome (DS) is characterised by premature aging and an accelerated decline of cognitive functions in the vast majority of cases. As the life expectancy of DS persons is rapidly increasing, this decline is becoming a dramatic health problem. The aim of this study was to thoroughly evaluate a group of 67 non-demented persons with DS of different ages (11 to 66 years), from a neuropsychological, neuropsychiatric and psychomotor point of view in order to evaluate in a cross-sectional study the age-related adaptive and neuropsychological features, and to possibly identify early signs predictive of cognitive decline. The main finding of this study is that both neuropsychological functions and adaptive skills are lower in adult DS persons over 40 years old, compared to younger ones. In particular, language and short memory skills, frontal lobe functions, visuo-spatial abilities and adaptive behaviour appear to be the more affected domains. A growing deficit in verbal comprehension, along with social isolation, loss of interest and greater fatigue in daily tasks, are the main features found in older, non demented DS persons evaluated in our study. It is proposed that these signs can be alarm bells for incipient dementia, and that neuro-cognitive rehabilitation and psycho-pharmacological interventions must start as soon as the fourth decade (or even earlier) in DS persons, i.e. at an age where interventions can have the greatest efficacy.